CCL5 and breast carcinoma: Breast cancer-derived exosomes were shown to promote a myofibroblastic phenotype in adipose tissue-derived mesenchymal stem cells, resulting in increased expression of the tumor-promoting factors, TGF-β, VEGF, stromal cell-derived factor 1 (SDF-1), and CCL5 [14].